389 related articles for article (PubMed ID: 27121194)
41. Clinical next-generation sequencing in patients with non-small cell lung cancer.
Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
[TBL] [Abstract][Full Text] [Related]
42. Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis.
Sabour L; Sabour M; Ghorbian S
Pathol Oncol Res; 2017 Apr; 23(2):225-234. PubMed ID: 27722982
[TBL] [Abstract][Full Text] [Related]
43. A straightforward assay to evaluate DNA integrity and optimize next-generation sequencing for clinical diagnosis in oncology.
Bettoni F; Koyama FC; de Avelar Carpinetti P; Galante PAF; Camargo AA; Asprino PF
Exp Mol Pathol; 2017 Dec; 103(3):294-299. PubMed ID: 29175301
[TBL] [Abstract][Full Text] [Related]
44. Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.
Carrick DM; Mehaffey MG; Sachs MC; Altekruse S; Camalier C; Chuaqui R; Cozen W; Das B; Hernandez BY; Lih CJ; Lynch CF; Makhlouf H; McGregor P; McShane LM; Phillips Rohan J; Walsh WD; Williams PM; Gillanders EM; Mechanic LE; Schully SD
PLoS One; 2015; 10(7):e0127353. PubMed ID: 26222067
[TBL] [Abstract][Full Text] [Related]
45. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
[TBL] [Abstract][Full Text] [Related]
46. Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors.
Ananda G; Mockus S; Lundquist M; Spotlow V; Simons A; Mitchell T; Stafford G; Philip V; Stearns T; Srivastava A; Barter M; Rowe L; Malcolm J; Bult C; Karuturi RK; Rasmussen K; Hinerfeld D
Exp Mol Pathol; 2015 Feb; 98(1):106-12. PubMed ID: 25562415
[TBL] [Abstract][Full Text] [Related]
47. Describing the Reportable Range Is Important for Reliable Treatment Decisions: A Multiple Laboratory Study for Molecular Tumor Profiling Using Next-Generation Sequencing.
Tack V; Spans L; Schuuring E; Keppens C; Zwaenepoel K; Pauwels P; Van Houdt J; Dequeker EMC
J Mol Diagn; 2018 Nov; 20(6):743-753. PubMed ID: 30055348
[TBL] [Abstract][Full Text] [Related]
48. Assessing the Value of Next-Generation Sequencing Tests in a Dynamic Environment.
Burris HA; Saltz LB; Yu PP
Am Soc Clin Oncol Educ Book; 2018 May; 38():139-146. PubMed ID: 30231307
[TBL] [Abstract][Full Text] [Related]
49. Occult Specimen Contamination in Routine Clinical Next-Generation Sequencing Testing.
Sehn JK; Spencer DH; Pfeifer JD; Bredemeyer AJ; Cottrell CE; Abel HJ; Duncavage EJ
Am J Clin Pathol; 2015 Oct; 144(4):667-74. PubMed ID: 26386089
[TBL] [Abstract][Full Text] [Related]
50. Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics.
Eijkelenboom A; Tops BBJ; van den Berg A; van den Brule AJC; Dinjens WNM; Dubbink HJ; Ter Elst A; Geurts-Giele WRR; Groenen PJTA; Groenendijk FH; Heideman DAM; Huibers MMH; Huijsmans CJJ; Jeuken JWM; van Kempen LC; Korpershoek E; Kroeze LI; de Leng WWJ; van Noesel CJM; Speel EM; Vogel MJ; van Wezel T; Nederlof PM; Schuuring E; Ligtenberg MJL
Virchows Arch; 2019 Jun; 474(6):673-680. PubMed ID: 30888490
[TBL] [Abstract][Full Text] [Related]
51. Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective.
Vigliar E; Malapelle U; de Luca C; Bellevicine C; Troncone G
Cytopathology; 2015 Oct; 26(5):271-83. PubMed ID: 26399861
[TBL] [Abstract][Full Text] [Related]
52. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
Mu W; Lu HM; Chen J; Li S; Elliott AM
J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
[TBL] [Abstract][Full Text] [Related]
53. Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays.
Kadri S; Long BC; Mujacic I; Zhen CJ; Wurst MN; Sharma S; McDonald N; Niu N; Benhamed S; Tuteja JH; Seiwert TY; White KP; McNerney ME; Fitzpatrick C; Wang YL; Furtado LV; Segal JP
J Mol Diagn; 2017 Jan; 19(1):43-56. PubMed ID: 27836695
[TBL] [Abstract][Full Text] [Related]
54. Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.
Hinrichs JW; van Blokland WT; Moons MJ; Radersma RD; Radersma-van Loon JH; de Voijs CM; Rappel SB; Koudijs MJ; Besselink NJ; Willems SM; de Weger RA
Am J Clin Pathol; 2015 Apr; 143(4):573-8. PubMed ID: 25780010
[TBL] [Abstract][Full Text] [Related]
55. Next-generation sequencing in precision oncology: challenges and opportunities.
Kruglyak KM; Lin E; Ong FS
Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
[TBL] [Abstract][Full Text] [Related]
56. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.
Wakai T; Prasoon P; Hirose Y; Shimada Y; Ichikawa H; Nagahashi M
Int J Clin Oncol; 2019 Feb; 24(2):115-122. PubMed ID: 30515675
[TBL] [Abstract][Full Text] [Related]
57. Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.
Sahm F; Schrimpf D; Jones DT; Meyer J; Kratz A; Reuss D; Capper D; Koelsche C; Korshunov A; Wiestler B; Buchhalter I; Milde T; Selt F; Sturm D; Kool M; Hummel M; Bewerunge-Hudler M; Mawrin C; Schüller U; Jungk C; Wick A; Witt O; Platten M; Herold-Mende C; Unterberg A; Pfister SM; Wick W; von Deimling A
Acta Neuropathol; 2016 Jun; 131(6):903-10. PubMed ID: 26671409
[TBL] [Abstract][Full Text] [Related]
58. A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma.
Shao D; Lin Y; Liu J; Wan L; Liu Z; Cheng S; Fei L; Deng R; Wang J; Chen X; Liu L; Gu X; Liang W; He P; Wang J; Ye M; He J
Sci Rep; 2016 Mar; 6():22338. PubMed ID: 26936516
[TBL] [Abstract][Full Text] [Related]
59. Review of Clinical Next-Generation Sequencing.
Yohe S; Thyagarajan B
Arch Pathol Lab Med; 2017 Nov; 141(11):1544-1557. PubMed ID: 28782984
[TBL] [Abstract][Full Text] [Related]
60. BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Janku F; Claes B; Huang HJ; Falchook GS; Devogelaere B; Kockx M; Bempt IV; Reijans M; Naing A; Fu S; Piha-Paul SA; Hong DS; Holley VR; Tsimberidou AM; Stepanek VM; Patel SP; Kopetz ES; Subbiah V; Wheler JJ; Zinner RG; Karp DD; Luthra R; Roy-Chowdhuri S; Sablon E; Meric-Bernstam F; Maertens G; Kurzrock R
Oncotarget; 2015 Sep; 6(29):26886-94. PubMed ID: 26330075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
